On March 10, Natalia Genere, MD had their review titled “Possible Association between Lenvatinib Use and Primary Adrenal Insufficiency: Additional Studies Very Much Needed,” published in “Clinical Thyroidology.” The review takes a look at a study showing how adverse events partnered with lenvatinib may lead to primary adrenal insufficiency. “Lenvatinib is a multitarget tyrosine kinase inhibitor approved for […]
Genere publishes review linking lenvatinib and primary adrenal insufficiency
![Natalia Genere, MD](https://endocrinology.wustl.edu/files/2021/11/natalia-genere-news-2021-760x507-1-350x233.jpg)